The epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) osimertinib is the current standard first-line therapy for patients with metastatic non–small cell lung cancer (NSCLC) ...

"She was officially diagnosed in August of 2024 with stage 4b cancer," said Chief John Haggerty with the Lehigh Township Volunteer Fire Company. Lubenetski fought for nine months.